Genetically Determined Procoagulant States and Heparin Use

Robert D. McBane

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The propensity for both arterial and venous thrombotic disorders involves a genetic predetermination that operates in concert with environmental factors or triggers. Appropriate clinical assessment and therapeutic recommendations for patients with thrombosis requires a thorough knowledge of genetic variables that influence this propensity. This review focuses on the pathophysiology, natural history, and molecular biology of defined thrombophilic risk factors relevant to the care of patients with thrombotic disorders.

Original languageEnglish (US)
Pages (from-to)427-442
Number of pages16
JournalSeminars in Cardiothoracic and Vascular Anesthesia
Volume7
Issue number4
StatePublished - Dec 2003

Fingerprint

Natural History
Heparin
Molecular Biology
Patient Care
Thrombosis
Therapeutics

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Genetically Determined Procoagulant States and Heparin Use. / McBane, Robert D.

In: Seminars in Cardiothoracic and Vascular Anesthesia, Vol. 7, No. 4, 12.2003, p. 427-442.

Research output: Contribution to journalArticle

@article{e9c5177fbf074560b612bef8e74b588f,
title = "Genetically Determined Procoagulant States and Heparin Use",
abstract = "The propensity for both arterial and venous thrombotic disorders involves a genetic predetermination that operates in concert with environmental factors or triggers. Appropriate clinical assessment and therapeutic recommendations for patients with thrombosis requires a thorough knowledge of genetic variables that influence this propensity. This review focuses on the pathophysiology, natural history, and molecular biology of defined thrombophilic risk factors relevant to the care of patients with thrombotic disorders.",
author = "McBane, {Robert D.}",
year = "2003",
month = "12",
language = "English (US)",
volume = "7",
pages = "427--442",
journal = "Seminars in Cardiothoracic and Vascular Anesthesia",
issn = "1089-2532",
publisher = "SAGE Publications Inc.",
number = "4",

}

TY - JOUR

T1 - Genetically Determined Procoagulant States and Heparin Use

AU - McBane, Robert D.

PY - 2003/12

Y1 - 2003/12

N2 - The propensity for both arterial and venous thrombotic disorders involves a genetic predetermination that operates in concert with environmental factors or triggers. Appropriate clinical assessment and therapeutic recommendations for patients with thrombosis requires a thorough knowledge of genetic variables that influence this propensity. This review focuses on the pathophysiology, natural history, and molecular biology of defined thrombophilic risk factors relevant to the care of patients with thrombotic disorders.

AB - The propensity for both arterial and venous thrombotic disorders involves a genetic predetermination that operates in concert with environmental factors or triggers. Appropriate clinical assessment and therapeutic recommendations for patients with thrombosis requires a thorough knowledge of genetic variables that influence this propensity. This review focuses on the pathophysiology, natural history, and molecular biology of defined thrombophilic risk factors relevant to the care of patients with thrombotic disorders.

UR - http://www.scopus.com/inward/record.url?scp=1242329399&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1242329399&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:1242329399

VL - 7

SP - 427

EP - 442

JO - Seminars in Cardiothoracic and Vascular Anesthesia

JF - Seminars in Cardiothoracic and Vascular Anesthesia

SN - 1089-2532

IS - 4

ER -